Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2006 1
2007 2
2008 5
2009 3
2010 3
2011 2
2012 1
2013 2
2014 3
2015 3
2016 3
2017 7
2018 3
2019 5
2020 4
2021 3
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
E2F1 as a molecular drug target in ovarian cancer.
Farra R, Dapas B, Grassi M, Benedetti F, Grassi G. Farra R, et al. Among authors: dapas b. Expert Opin Ther Targets. 2019 Mar;23(3):161-164. doi: 10.1080/14728222.2019.1579797. Epub 2019 Feb 8. Expert Opin Ther Targets. 2019. PMID: 30724632 No abstract available.
An Overview of siRNA Delivery Strategies for Urological Cancers.
Halib N, Pavan N, Trombetta C, Dapas B, Farra R, Scaggiante B, Grassi M, Grassi G. Halib N, et al. Among authors: dapas b. Pharmaceutics. 2022 Mar 27;14(4):718. doi: 10.3390/pharmaceutics14040718. Pharmaceutics. 2022. PMID: 35456552 Free PMC article. Review.
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.
Jesenko T, Brezar SK, Cemazar M, Biasin A, Tierno D, Scaggiante B, Grassi M, Grassi C, Dapas B, Truong NH, Abrami M, Zanconati F, Bonazza D, Rizzolio F, Parisi S, Pastorin G, Grassi G. Jesenko T, et al. Among authors: dapas b. Pharmaceutics. 2023 Apr 15;15(4):1249. doi: 10.3390/pharmaceutics15041249. Pharmaceutics. 2023. PMID: 37111734 Free PMC article. Review.
Strategies for Delivery of siRNAs to Ovarian Cancer Cells.
Farra R, Maruna M, Perrone F, Grassi M, Benedetti F, Maddaloni M, El Boustani M, Parisi S, Rizzolio F, Forte G, Zanconati F, Cemazar M, Kamensek U, Dapas B, Grassi G. Farra R, et al. Among authors: dapas b. Pharmaceutics. 2019 Oct 22;11(10):547. doi: 10.3390/pharmaceutics11100547. Pharmaceutics. 2019. PMID: 31652539 Free PMC article. Review.
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.
Scarabel L, Perrone F, Garziera M, Farra R, Grassi M, Musiani F, Russo Spena C, Salis B, De Stefano L, Toffoli G, Rizzolio F, Tonon F, Abrami M, Chiarappa G, Pozzato G, Forte G, Grassi G, Dapas B. Scarabel L, et al. Among authors: dapas b. Expert Opin Drug Deliv. 2017 Jun;14(6):797-810. doi: 10.1080/17425247.2017.1292247. Epub 2017 Feb 17. Expert Opin Drug Deliv. 2017. PMID: 28266887 Review.
Potential Applications of Nanocellulose-Containing Materials in the Biomedical Field.
Halib N, Perrone F, Cemazar M, Dapas B, Farra R, Abrami M, Chiarappa G, Forte G, Zanconati F, Pozzato G, Murena L, Fiotti N, Lapasin R, Cansolino L, Grassi G, Grassi M. Halib N, et al. Among authors: dapas b. Materials (Basel). 2017 Aug 21;10(8):977. doi: 10.3390/ma10080977. Materials (Basel). 2017. PMID: 28825682 Free PMC article. Review.
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness.
Farra R, Musiani F, Perrone F, Čemažar M, Kamenšek U, Tonon F, Abrami M, Ručigaj A, Grassi M, Pozzato G, Bonazza D, Zanconati F, Forte G, El Boustani M, Scarabel L, Garziera M, Russo Spena C, De Stefano L, Salis B, Toffoli G, Rizzolio F, Grassi G, Dapas B. Farra R, et al. Among authors: dapas b. Molecules. 2018 Mar 28;23(4):777. doi: 10.3390/molecules23040777. Molecules. 2018. PMID: 29597300 Free PMC article. Review.
52 results